Elucidating the Molecular Determinants of Aβ Aggregation with Deep Mutational Scanning
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Despite the importance of Aβ aggregation in Alzheimer’s disease etiology, our understanding of the sequence determinants of aggregation is sparse and largely derived from in vitro studies. For example, in vitro proline and alanine scanning mutagenesis of Aβ40 proposed core regions important for aggregation. However, we lack even this limited mutagenesis data for the more disease-relevant Aβ42. Thus, to better understand the molecular determinants of Aβ42 aggregation in a cell-based system, we combined a yeast DHFR aggregation assay with deep mutational scanning. We measured the effect of 791 of the 798 possible single amino acid substitutions on the aggregation propensity of Aβ42. We found that ∼75% of substitutions, largely to hydrophobic residues, maintained or increased aggregation. We identified 11 positions at which substitutions, particularly to hydrophilic and charged amino acids, disrupted Aβ aggregation. These critical positions were similar but not identical to critical positions identified in previous Aβ mutagenesis studies. Finally, we analyzed our large-scale mutagenesis data in the context of different Aβ aggregate structural models, finding that the mutagenesis data agreed best with models derived from fibrils seeded using brain-derived Aβ aggregates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022 · cited 1×
“The most aggregation-prone form of Aβ is 42 amino acids long (Aβ42), though Aβ40 is present at higher concentrations in human cerebrospinal fluid (Jarrett et al. 1993; Iwatsubo et al. 1994; Dahlgren et al. 2002).”
Iwatsubo, T., Odaka, A., Suzuki, N., Mizusawa, H., Nukina, N., & Ihara, Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90458-8 · Cited by 1,774 · cited 1×
“The most aggregation-prone form of Aβ is 42 amino acids long (Aβ42), though Aβ40 is present at higher concentrations in human cerebrospinal fluid (Jarrett et al. 1993; Iwatsubo et al. 1994; Dahlgren et al. 2002).”
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452
Deep mutational scanning: a new style of protein science
Fowler, D. M., & Fields, S. (2014) · Nature Methods · doi:10.1038/nmeth.3027 · Cited by 1,287 · cited 2×
“Thus, to fully understand the molecular determinants of Aβ42 aggregation in a cell-based system, we combined the yeast DHFR aggregation assay with deep mutational scanning (Araya and Fowler 2011; Fowler and Fields 2014; Fowler et al. 2014) to measure the effect of 791 of the possible 798 single amino acid substitution…”
Self-citationThirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Bertram, L., & Tanzi, R. E. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2494 · Cited by 747 · cited 2×
“…and epidemiological work suggests that aggregation of the amyloid β (Aβ) peptide is related to the incurable neurodegeneration associated with Alzheimer’s disease (Hardy and Selkoe 2002; Lesné et al. 2008; Bertram and Tanzi 2008; Shankar et al. 2009; Masters and Selkoe 2012; Hardy 2017).”
Treusch, S., Hamamichi, S., Goodman, J. L., Matlack, K. E. S., Chung, C. Y., Baru, V., Shulman, J. M., Parrado, A., Bevis, B. J., Valastyan, J. S., et al. (2011) · Science · doi:10.1126/science.1213210 · Cited by 379
A statistical framework for analyzing deep mutational scanning data
Rubin, A. F., Gelman, H., Lucas, N., Bajjalieh, S. M., Papenfuss, A. T., Speed, T. P., & Fowler, D. M. (2017) · Genome Biology · doi:10.1186/s13059-017-1272-5 · Cited by 262 · cited 2×
“Enrich2 was used to calculate solubility scores for each Aβ variant from sequencing fastq files (Rubin et al. 2017).”
MethodSelf-citationHardy, J. (2017) · The FEBS Journal · doi:10.1111/febs.14004 · Cited by 153 · cited 2×
“…and epidemiological work suggests that aggregation of the amyloid β (Aβ) peptide is related to the incurable neurodegeneration associated with Alzheimer’s disease (Hardy and Selkoe 2002; Lesné et al. 2008; Bertram and Tanzi 2008; Shankar et al. 2009; Masters and Selkoe 2012; Hardy 2017).”
Cited by
Disease variant prediction with deep generative models of evolutionary data
Frazer, J., Notin, P., Dias, M., Gomez, A., Min, J. K., Brock, K., Gal, Y., & Marks, D. S. (2021) · Nature · doi:10.1038/s41586-021-04043-8 · Cited by 791
(2023) · doi:10.1101/2023.12.07.570727 · Cited by 207
The landscape of tolerated genetic variation in humans and primates
(2023) · doi:10.1126/science.abn8197 · Cited by 182
Lindorff-Larsen, K., & Kragelund, B. B. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167196 · Cited by 85
Flattening the curve—How to get better results with small deep‐mutational‐scanning datasets
Wirnsberger, G., Pritišanac, I., Oberdorfer, G., & Gruber, K. (2024) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.26686 · Cited by 3
Metadata
- Authors
- Gray, V. E., Sitko, K., Kameni, F. Z. N., Williamson, M., Stephany, J. J., Hasle, N., & Fowler, D. M.
- Venue
- G3 Genes|Genomes|Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-11-01
- Volume
- 9
- Issue
- 11
- Pages
- 3683-3689
- ISSN
- 2160-1836 (ISSN-L)
- OpenAlex
- W2975488016
- Cited by
- 38
- References
- 8
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.